NICE recommends Novartis’ previously CDF-exclusive kidney cancer treatment
January 13, 2017Medical Communications, Sales and Marketing Afinitor, CDF, NICE, Novartis, everolimus
In a reappraisal decision by NICE, everolimus (Novartis’ Afinitor) has been recommended for the treatment of advanced renal cell carcinoma …
Welsh government launches £80 million fund for newly approved drugs
January 13, 2017Medical Communications Wales, Welsh Government, drug fund
The Welsh Government has created a five-year £80 million drug fund, which will work out to an additional £16 million …
Drugstore chain CVS offers EpiPen generic for 600% cheaper
January 12, 2017Medical Communications, Sales and Marketing CVS, Mylan, epipen
The Mylan EpiPen scandal was one of last year’s most closely-followed stories, as the industry reacted with scorn to CEO …
IBM and FDA collaborate to protect patient data with blockchain technology
January 12, 2017Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm
IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …
Takeda invests $125m in Maverick T-cell platform partnership
January 12, 2017Research and Development Maverick, Takeda
Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …
Mylan and Biocon apply to FDA for biosimilar approval
January 12, 2017Sales and Marketing Biocon, FDA, Mylan, biosimilar, trastuzumab
Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …
Shire fined $350 million in largest-ever bribery case of its kind
January 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice
Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …
New immunotherapy-based cancer research limits cancer spread by 75%
January 12, 2017Medical Communications, Research and Development Cancer, cancer research, immunotherapy
Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …
Rio De Janeiro’s primary airport awarded CEIV Pharma certification
January 11, 2017Manufacturing and Production Rio Galeao, cargo
Rio Galeão, the main airport serving Rio De Janeiro, has been awarded Centre of Excellence for Independent Validators (CEIV) Pharma …
MSD and Lilly announce immuno-oncology collaboration
January 11, 2017Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly
MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …
MPS extends its range of child resistant packaging
January 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions
MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …
MSD looks to jump the gun with combination immunotherapy application
January 11, 2017Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda
MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …
Philips and Illumina partner up for integrated genomics oncology solution
January 11, 2017Research and Development Illumina, Philips, oncology
Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …
New formulary ‘bank’ to aid research into combination therapies
January 11, 2017Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy
As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …
Daiichi pulls out of India with closure of 170-strong R&D plant
January 11, 2017Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma
Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …
FDA warns that St. Jude’s heart devices could be hacked
January 11, 2017Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec
The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …
Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE)
January 10, 2017Medical Equipment Supplier, SCOPE2017
Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE) Woodley Equipment Company is exhibiting at Summit for Clinical …
SHL brings innovation to Pharmapack Europe 2017
January 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing auto injector, connectivity, delivery devices, smart packaging
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …
Research finds cancer cells spread even before tumour development
January 10, 2017Manufacturing and Production, Research and Development Cancer
Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …
Egalet gains FDA approval for difficult to abuse painkiller
January 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing Arymo ER, Egalet Corp, FDA
Egalet has gained FDA approval for Arymo ER, a long-acting opioid painkiller that is made to be difficult to breakdown. …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
